Resultados de la búsqueda 771-780 of 4803 for Lupus

  1. Neurología - Ensayos clínicos

    We aim to determine whether cognitive impairment attributable to cerebral hemodynamic impairment in patients with high-grade asymptomatic carotid artery ...

  2. Cirugía - Ensayos clínicos

    Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer. This study hopes ...

  3. Ensayos clínicos - Neurología

    This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to ...

  4. Ensayos clínicos - Neurología

    The purpose of this study is to evaluate the safety and effectiveness of using Exablate Model 4000 Type-2.0/2.1 in adults with Glioblastoma brain tumors to ...

  5. Ensayos clínicos - Neurología

    This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to ...

  6. Departamento de Oftalmología de Mayo Clinic - Ensayos clínicos

    Early Detection of Glaucomatous Optic Neuropathy ... Rochester, Minn. The goal of this study is to determine if visual field assessment of the far periphery (60-4) ...

  7. Oncología (médica) - Ensayos clínicos

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  8. Ensayos clínicos - Neurología

    This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to ...

  9. Hematología - Ensayos clínicos

    This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the ...

  10. Oncología (médica) - Ensayos clínicos

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status. The percentage ...